BIOMAT Database Logo BIOMAT Database Logo

Biological evaluation of fluorinated p-boronophenylalanine derivatives as a boron carrier. 2007

Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Faculty of Science and Technology, Kinki University, Higashi-osaka, Osaka 577-8502, Japan.

Boron neutron capture therapy (BNCT) and magnetic resonance imaging (MRI) are quite attractive techniques for treatment and diagnosis of cancer, respectively. In order to develop practical materials utilizing both for BNCT and MRI, fluorinated p-boronophenylalanines and their alcohol derivatives had already been designed and synthesized. In the present paper the cytotoxicity, the incorporated amount into cancer cells, and the tumor cell killing effects of these compounds were elucidated to evaluate their usefulness as a boron carrier.

UI MeSH Term Description Entries
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D010649 Phenylalanine An essential aromatic amino acid that is a precursor of MELANIN; DOPAMINE; noradrenalin (NOREPINEPHRINE), and THYROXINE. Endorphenyl,L-Phenylalanine,Phenylalanine, L-Isomer,L-Isomer Phenylalanine,Phenylalanine, L Isomer
D001895 Boron A trace element with the atomic symbol B, atomic number 5, and atomic weight [10.806; 10.821]. Boron-10, an isotope of boron, is used as a neutron absorber in BORON NEUTRON CAPTURE THERAPY. Boron-11,Boron 11
D001896 Boron Compounds Inorganic or organic compounds that contain boron as an integral part of the molecule. Borides,Compounds, Boron
D002470 Cell Survival The span of viability of a cell characterized by the capacity to perform certain functions such as metabolism, growth, reproduction, some form of responsiveness, and adaptability. Cell Viability,Cell Viabilities,Survival, Cell,Viabilities, Cell,Viability, Cell
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D004354 Drug Screening Assays, Antitumor Methods of investigating the effectiveness of anticancer cytotoxic drugs and biologic inhibitors. These include in vitro cell-kill models and cytostatic dye exclusion tests as well as in vivo measurement of tumor growth parameters in laboratory animals. Anticancer Drug Sensitivity Tests,Antitumor Drug Screens,Cancer Drug Tests,Drug Screening Tests, Tumor-Specific,Dye Exclusion Assays, Antitumor,Anti-Cancer Drug Screens,Antitumor Drug Screening Assays,Tumor-Specific Drug Screening Tests,Anti Cancer Drug Screens,Anti-Cancer Drug Screen,Antitumor Drug Screen,Cancer Drug Test,Drug Screen, Anti-Cancer,Drug Screen, Antitumor,Drug Screening Tests, Tumor Specific,Drug Screens, Anti-Cancer,Drug Screens, Antitumor,Drug Test, Cancer,Drug Tests, Cancer,Screen, Anti-Cancer Drug,Screen, Antitumor Drug,Screens, Anti-Cancer Drug,Screens, Antitumor Drug,Test, Cancer Drug,Tests, Cancer Drug,Tumor Specific Drug Screening Tests
D005910 Glioma Benign and malignant central nervous system neoplasms derived from glial cells (i.e., astrocytes, oligodendrocytes, and ependymocytes). Astrocytes may give rise to astrocytomas (ASTROCYTOMA) or glioblastoma multiforme (see GLIOBLASTOMA). Oligodendrocytes give rise to oligodendrogliomas (OLIGODENDROGLIOMA) and ependymocytes may undergo transformation to become EPENDYMOMA; CHOROID PLEXUS NEOPLASMS; or colloid cysts of the third ventricle. (From Escourolle et al., Manual of Basic Neuropathology, 2nd ed, p21) Glial Cell Tumors,Malignant Glioma,Mixed Glioma,Glial Cell Tumor,Glioma, Malignant,Glioma, Mixed,Gliomas,Gliomas, Malignant,Gliomas, Mixed,Malignant Gliomas,Mixed Gliomas,Tumor, Glial Cell,Tumors, Glial Cell
D006845 Hydrocarbons, Fluorinated Inert liquid or gaseous halocarbon compounds in which FLUORINE replaces some or all HYDROGEN atoms. Fluorinated Hydrocarbons
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia

Related Publications

Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Hydroxylforms of p-boronophenylalanine as potential boron carriers on boron neutron capture therapy for malignant brain tumors.
May 1996, Cancer research,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Boron neutron capture therapy of anterior chamber melanoma with p-boronophenylalanine.
February 1992, Investigative ophthalmology & visual science,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
1H MRS studies in the Finnish boron neutron capture therapy project: detection of 10B-carrier, L-p-boronophenylalanine-fructose.
November 2005, European journal of radiology,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Central nervous system tolerance to boron neutron capture therapy with p-boronophenylalanine.
January 1997, British journal of cancer,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Selective uptake of p-boronophenylalanine by osteosarcoma cells for boron neutron capture therapy.
July 2009, Applied radiation and isotopes : including data, instrumentation and methods for use in agriculture, industry and medicine,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Assessing the effectiveness of fluorinated and α-methylated 3-boronophenylalanine for improved tumor-specific boron delivery in boron neutron capture therapy.
January 2024, Bioorganic chemistry,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
1H MRS of a boron neutron capture therapy 10B-carrier, L-p-boronophenylalanine-fructose complex, BPA-F: phantom studies at 1.5 and 3.0 T.
April 2003, Physics in medicine and biology,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Synthesis and biological evaluation of thiophenylbenzofuran derivatives as potential P-glycoprotein inhibitors.
September 2020, European journal of medicinal chemistry,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Control of intracerebral gliosarcomas in rats by boron neutron capture therapy with p-boronophenylalanine.
March 1992, Radiation research,
Yoshihide Hattori, and Kei Kurihara, and Hirofumi Kondoh, and Tomoyuki Asano, and Mitsunori Kirihata, and Yoshihiro Yamaguchi, and Tateaki Wakamiya
Synthesis and biological properties of water-soluble p-boronophenylalanine derivatives. Relationship between water solubility, cytotoxicity, and cellular uptake.
May 1995, Journal of medicinal chemistry,
Copied contents to your clipboard!